Securities class action settlements
Securities class action settlements for shareholders and investors over alleged fraud or misstatements.
Securities settlements by the numbers
A settlement fund is the total a defendant agreed to pay, not what any one claimant receives — most funds are divided among everyone who files. Settlements are negotiated agreements, and defendants typically deny wrongdoing rather than being found liable.
The 98 settlements in this category that publish a fund, grouped by size. Most cluster low and a few are very large — which is why the headline figure above is a median rather than an average.
| Fund size | Settlements | Share | |
|---|---|---|---|
| Under $1M | 0 | 0% | |
| $1M – $5M | 3 | 3% | |
| $5M – $25M | 47 | 48% | |
| $25M – $100M | 35 | 36% | |
| $100M and up | 13 | 13% |
A fund is the total a defendant agreed to pay, not an individual payout.
Get new claim opportunities by email
Free alerts for new settlements and deadlines. Unsubscribe anytime.
Accepting claims now
Revance Securities Settlement
Revance Therapeutics and its executives made material misrepresentations and omissions regarding the company's relationship with Teoxane SA and the tender offer and merger transaction with Crown Laboratories, Inc., allegedly violating federal securities laws. Defendants deny any wrongdoing or liability.
Not yet determinable; depends on number of valid claims submitted
Biogen Securities Litigation Settlement
Biogen Inc. investors have settled a securities litigation case for $18.9 million in cash. The settlement resolves claims related to purchases of Biogen common stock during the specified class period.
NJ Bureau of Securities Settlement with Credit Suisse
Credit Suisse allegedly violated New Jersey Securities Law by making materially false and misleading statements regarding RMBS trust certificates and engaging in fraudulent practices. On October 24, 2022, the court entered a consent order requiring Credit Suisse to pay $300 million in restitution to investors. Credit Suisse neither admitted nor denied the allegations.
Stitch Fix Securities Litigation Settlement
Stitch Fix, Inc. is settling a securities class action lawsuit without admitting wrongdoing. The Lead Plaintiffs alleged that Stitch Fix issued misleading statements about its business, and shareholders who purchased the stock during the class period suffered damages as a result.
Vintage Wine Securities Settlement
Vintage Wine Estates, Inc. allegedly violated federal securities laws. The defendants deny any wrongdoing and assert that no damages were suffered. The settlement resolves these claims for $7.5 million.
Up to $0.79
Eagle Pharma Securities Litigation Settlement
Eagle Pharmaceuticals, Inc. is the subject of a securities litigation class action. Shareholders who purchased the company's publicly traded common stock between August 9, 2022 and October 1, 2024 allege claims covered by this settlement, which the defendant has agreed to settle.
Kornit Digital Ltd. Securities Litigation Settlement
Kornit Digital Ltd. and its executives were sued for alleged securities fraud. The defendants deny any wrongdoing and have agreed to settle to avoid the expense and burden of continued litigation. The settlement does not constitute an admission of fault by the defendants.
Closed to new claims
Past the filing deadline — kept so you can look up what a case was about and what it paid.
Virgin Galactic Holdings Securities Settlement
Plaintiffs claim that defendants violated federal securities laws in connection with publicly traded shares of Virgin Galactic Holdings, Inc. and Social Capital Hedosophia Holdings Corp. Defendants deny all wrongdoing and deny that they violated any laws or that any member of the settlement class suffered damages.
Paid $0.00–$0.08
Evolv Technologies Holdings Securities Settlement
Investors purchased publicly traded common stock of Evolv Technologies Holdings Inc. during a specific period and are entitled to compensation from a securities class action settlement. The page does not explicitly state what wrongdoing Evolv allegedly committed.
E-Commerce China Dangdang Securities Settlement
E-Commerce China Dangdang, Inc. was involved in a take-private transaction (merger) that closed on September 20, 2016. Shareholders who held American Depositary Shares during the Class Period claim they were harmed by undisclosed information related to the Company's take-private transaction. The defendant has agreed to settle these securities claims without admitting wrongdoing.
Estée Lauder Securities Settlement
Estée Lauder is settling securities litigation relating to alleged damages to investors who purchased or acquired publicly traded common stock of The Estée Lauder Companies Inc. during the class period. The defendant has not admitted wrongdoing in this settlement.
Tattooed Chef Securities Settlement
Tattooed Chef, Inc. faced a securities lawsuit alleging that purchasers of the company's common stock were damaged. The defendant has agreed to settle all claims in the action for $4,750,000 in cash without admitting wrongdoing.
Doximity Securities Litigation Settlement
The Court-appointed Lead Plaintiff settled the securities litigation against Doximity for $31,000,000 in cash. Class members purchased or acquired Doximity common stock during the specified period and were damaged by the alleged conduct.
Mylan N.V. Securities Litigation Settlement
Mylan N.V. and certain executives (CEO Heather Bresch, President Rajiv Malik, and CFO Kenneth Parks) are settling a securities class action lawsuit. The defendants deny wrongdoing and have agreed to the settlement solely to eliminate the burden and expense of continued litigation.
Driven Brands Securities Litigation Settlement
Driven Brands Holdings Inc. and executives Jonathan G. Fitzpatrick (former CEO) and Tiffany L. Mason (former CFO) allegedly violated federal securities laws by making false and misleading statements about the company's business. The company has agreed to settle the claims for $25,000,000 in cash.
PG&E Corporation Securities Litigation Settlement
PG&E Corporation issued certain securities during the Class Period. Plaintiffs alleged they were damaged by misrepresentations or omissions regarding PG&E's business during this time. The defendant has agreed to settle the claims for $100 million without admitting wrongdoing.
BioXcel Therapeutics Securities Settlement
BioXcel Therapeutics and its executives allegedly violated federal securities laws by making materially false or misleading statements and omissions regarding the company's business. Defendants deny wrongdoing and settled to avoid the costs and risks of continued litigation.
Paid $1.10–$1.52
Arqit Quantum Inc. Securities Settlement
Arqit Quantum Inc. (formerly Centricus Acquisition Corp.) and its executives allegedly made false or misleading statements and omissions regarding the company in connection with a merger and the offering of securities to investors. Defendants deny all wrongdoing and liability.
Paid Up to $0.23
Hayward Holdings, Inc. Securities Litigation
Defendants Hayward Holdings, Inc., its CEO, and CFO allegedly made materially false and misleading statements and omissions regarding inventory, growth, and demand trends for Hayward's pool products during the class period. The allegations claim that the stock traded at artificially inflated prices as a result, and shareholders suffered damages when the truth was revealed and the stock price declined.
Paid Cannot be determined at this time; payments will be distributed pro rata according to the Plan of Allocation after deductions for taxes, attorneys' fees, expenses, and claims administration costs.
Hayward Holdings, Inc. Securities Litigation Settlement
Hayward Holdings, Inc. and its CEO and CFO allegedly made materially false and misleading statements and omissions regarding inventory, growth, and demand trends for Hayward's pool products during October 27, 2021 through July 28, 2022. As a result, Hayward's stock traded at artificially inflated prices, and shareholders suffered damages when the stock price declined after the alleged truth was revealed. Defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
Paid Individual payout amounts cannot be determined at this time and will be distributed pro rata based on the Plan of Allocation after deductions for taxes, attorneys' fees, expenses, service award, and claims administration costs.
Osprey Stockholder Litigation Settlement
Osprey Technology Corp. stockholders allege that the defendants failed to properly value and handle their Class A common stock. The defendants have agreed to pay $7,500,000 to settle the claims without admitting wrongdoing.
GGI Stockholder Settlement
Gores Guggenheim, Inc. (GGI), now known as Polestar Automotive Holding UK PLC, completed a merger that closed on June 23, 2022. Shareholders allege claims against the defendants related to the merger transaction, and the defendants have agreed to settle all claims for $25 million in cash without admitting wrongdoing.
NCAA Volunteer Coaches Lawsuit Settlement
The NCAA and its Division I member schools allegedly agreed through NCAA bylaws to prohibit paying compensation or benefits to volunteer coaches, which Plaintiffs claim was an illegal wage-fixing conspiracy under the Sherman Act. Volunteer coaches during the class period claim they were injured by this alleged conspiracy and seek damages based on what their compensation would have been absent the illegal agreement.
Paid Net Settlement Fund (after attorney fees, costs, expenses, and service awards) divided equally among all Class Members who file timely and valid Claim Forms
AlphaCentric Income Opportunities Fund Securities Settlement
AlphaCentric Income Opportunities Fund investors allege they were harmed through misrepresentations or improper conduct related to shares of the Fund. The defendants deny any wrongdoing but have agreed to settle for $20 million plus interest.
Catalent Securities Settlement
Catalent, Inc. is facing a securities class action lawsuit brought by the City of Warwick Retirement System on behalf of investors. The settlement resolves claims related to publicly traded common stock and options that allegedly experienced price issues during the class period from August 30, 2021 through May 7, 2023.
CMLS III Stockholder Settlement
Plaintiffs brought a class action lawsuit against defendants related to CM Life Sciences III, Inc. stock held by shareholders. The defendants have agreed to settle for $7,250,000 in cash. The defendants deny all claims and allegations of wrongdoing.
EIC Stockholder Settlement
Plaintiffs sued defendants in connection with EIC Class A Common Stock. The defendants, including the Sponsor and EIC board members, have agreed to settle all claims for $17,775,000 in cash. The settlement resolves the class action without the defendants admitting any wrongdoing.
HighCape Stockholder Settlement
HighCape Capital and related defendants were sued by shareholders over their conduct related to HighCape Capital Acquisition Corp. The defendants deny all claims and allegations of wrongdoing, but have agreed to settle the class action lawsuit for $7.6 million.
Snap Inc. Securities Settlement
Snap Inc. is paying $65 million to settle a class action securities lawsuit. The settlement resolves claims that purchasers and sellers of Snap Inc. securities were damaged by alleged misconduct during the class period.
Masimo Securities Settlement
Masimo Corporation allegedly made misleading statements or omissions regarding its publicly traded common stock. Shareholders claim they were damaged by purchasing or acquiring the stock during the class period.
dMY Technology Group, Inc. II Stockholder Litigation Settlement
dMY Technology Group, Inc. II is involved in stockholder litigation. Plaintiffs Aaron Offringa and Michael Farzad, on behalf of the Class, alleged claims against dMY Sponsor II and other defendants. The defendants have agreed to settle for $14,800,000.00 in cash to resolve all claims without admitting wrongdoing.